Is oklo stock (oklo) and buy now?


Nuclear commissioning ok hey (Nyse: Oklo) it was one of the stock market’s explosive success stories of 2025 (although I probably shouldn’t use the word “explosive” when talking about a company that makes nuclear reactors). The stock hit an all-time high in October shortly after Oklo began building its first small modular reactor (SMR) facility, the Aurora Powerhouse.

Since then, however, the market has not been kind to the company (or to nuclear initiatives in general). Oklo’s share price has fallen more than 60% since its October highs:

Where to invest $1000 right now? Our team of analysts just revealed what they think they are 10 best stocks buy now, when you join Stock Advisor. View stocks »

Is this a sign of more bad news to come? Or at this price, is Oklo a buy now?

Oklo is a nuclear start-up in the pre-commercial phase. This means that the company has not yet begun commercial operations and does not expect to begin until late 2027 or early 2028. Therefore, metrics such as quarterly revenue, profitability and price-to-sales ratio do not reflect Oklo’s long-term outlook. Investors will have to wait at least two years before this data makes sense.

A person with his head in his hands surrounded by stacks of papers.
Image source: Getty Images.

Meanwhile, Oklo’s share price movements are driven by news about the company, its rivals, the nuclear industry in general and how analysts and major investors view the stock. For example, when Cathie Wood’s Ark Autonomous Technology & Robotics ETF sold a quarter of its position in Oklo in September, the stock price took an immediate hit. Since then, the fund has bought back more shares than it sold.

In other words, investors buying shares now are bracing themselves for at least two years of volatility and unexpected price swings before they know whether the company’s technology will perform as planned. Buying Oklo now is only for investors who can bear that risk, and even they should only use money they can afford to lose.

One of the biggest obstacles to building and operating a nuclear power plant in the US is the amount of red tape that needs to be managed. The Nuclear Regulatory Commission (NRC) must approve the design, construction and operation of this facility before it can ever be licensed for commercial power generation. The whole approval process takes years, even if there is no problem that needs to be solved. Until full approval is granted, any commercial nuclear project is essentially stuck in limbo.

Oklo is in the middle of its regulatory journey. It proposes to design, build and operate its reactors, then sell the power it generates to customers, so it is applying for a combined license from the NRC, which will include design, construction and operational approval. Although it has not yet received such combined approval from the NRC, its Aurora Powerhouse project in Idaho was accepted into the US Department of Energy’s Reactor Pilot Program (RPP) last year. The purpose of the RPP is to accelerate the testing and deployment of advanced nuclear reactors such as Oklo.

It is unclear how participation in the RPP will affect the timing and approval process of the NRC. As a result, according to an Oklo spokesperson, the company has decided to focus on its RPP obligations rather than its NRC applications for now, and hopes that its participation in RPP will help streamline the final NRC review process. There’s no guarantee this strategy will result in an accelerated approval timeline for the NRC’s Aurora, Idaho plant, but it certainly can’t hurt.

Given all the uncertainty inherent in this industry, it’s no surprise that changing the first two letters to “nuclear” means “unclear” — most investors will want to wait for more clarity before buying Oklo stock. This is perfectly valid. Speculative stocks like this are certainly not for everyone.

That said, Oklo’s stock price hasn’t been this low since September and is likely to immediately rise again if any regulatory progress or other favorable news is announced. Buying now allows investors to take advantage of these gains, rather than buying later for more certainty, but with lower potential returns. If you think, as I do, that Oklo is likely to get NRC approval, it might be worth taking a small position today. Just make sure you are aware of the risks.

Before you buy shares in Oklo, keep this in mind:

The Motley Fool Stock Advisor The team of analysts has just identified what they think they are 10 best stocks because investors are buying now… and Oklo was not one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you would have $443,299!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you would have $1,136,601!*

Now, it’s worth noting Stock advisor The total average performance is 914%: Outperformed the market compared to 195% of the S&P 500. Don’t miss the latest top 10 list, available with Stock advisorand join an investment community created by individual investors for individual investors.

See the 10 actions »

* Stock Advisor returns from February 8, 2026.

John Bromels has charges in Oklo. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has one disclosure policy.

Is oklo stock (oklo) and buy now? was originally published by The Motley Fool



Source link

  • Related Posts

    National Health Investors stock hit a 52-week high of $85.20

    National Health Investors stock hit a 52-week high of $85.20 Source link

    Market update: CNC, SHEL, VSH, PSX, PLTR

    Market update: CNC, SHEL, VSH, PSX, PLTR Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *